Genelux GNLX
NASDAQ GNLX
$2.37 -0.13 (-5.19%)
As of: Oct 21, 2026 · 1:26 PM EDT

Genelux (GNLX) Revenue (2022 - 2024)

Updated

Genelux's Revenue was $8,000 in FY2025, unchanged from $8,000 in FY2024.

Analysis

Genelux (GNLX) Revenue (2022 - 2024) Analysis & Trends

From FY2022 onward, Genelux has reported Revenue for 4 years.

  • Revenue shows a three-year compound annual growth rate of -91.0% (FY2022 to FY2025).
  • Annual Revenue has moved between $8,000 (FY2024) and $11.07 million (FY2022) over five years.
  • Per Business Quant data, Revenue in earlier years was $8,000 in FY2024 (-95.3%), $170,000 in FY2023 (-98.5%) and $11.07 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn 25.31 Bn
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn 16.99 Bn
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 15.03 Bn
10 Genelux 105.19 Mn 43.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 8,000.00
Mar 31, 2023 170,000.00
Dec 31, 2022 68,000.00
Sep 30, 2022 11.00 Mn
API Access

Genelux Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=GNLX&period=max&api_key=YOUR_API_KEY